Heterogeneity in COVID-19-related risk of death has been identified across different cancer subtypes
Significant heterogeneity has been identified at risk of coronavirus disease 2019 (COVID-19) – associated mortality in patients based on factors such as cancer subtype, age, sex, and patient …
